We are live on
!
Find out more
NPF
Norris Perne & French Portfolio holdings
AUM
$1.71B
1-Year Est. Return
30.87%
This Fund
S&P 500
This Quarter
Est. Return
+8.46%
1 Year Est. Return
+30.87%
3 Year Est. Return
+78.29%
5 Year Est. Return
+102.93%
10 Year Est. Return
+464.45%
AUM
$1.19B
AUM Growth
+$95.7M
(+8.8%)
Cap. Flow
+$13.7M
Cap. Flow
% of AUM
1.15%
Top 10 Holdings %
Top 10 Hldgs %
33.09%
Holding
138
New
5
Increased
59
Reduced
31
Closed
8
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Kenvue
KVUE
|
+$12M |
| 2 |
iShares Russell 1000 Value ETF
IWD
|
+$3.45M |
| 3 |
Johnson & Johnson
JNJ
|
+$709K |
| 4 |
Danaher
DHR
|
+$646K |
| 5 |
L3Harris
LHX
|
+$615K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Verisk Analytics
VRSK
|
+$6.04M |
| 2 |
Qualcomm
QCOM
|
+$2.9M |
| 3 |
Apple
AAPL
|
+$700K |
| 4 |
Microsoft
MSFT
|
+$402K |
| 5 |
Bank of America Series L
BAC.PRL
|
+$307K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 29.53% |
| 2 | Industrials | 13.92% |
| 3 | Healthcare | 10.8% |
| 4 | Consumer Discretionary | 9.85% |
| 5 | Financials | 8.35% |
Similar funds
ACM
II
RSCM
OMC
WJA
BCM
ESBC
PP
Norris Perne & French's Q2 2023 Portfolio in Review
As of Q2 2023, Norris Perne & French held 138 positions worth $1.19B, up 8.8% from $1.09B the previous quarter. Its ten largest holdings account for 33% of the portfolio.
Norris Perne & French's Q2 2023 filing shows 5 new, 59 increased, 31 reduced and 8 closed positions. Its largest new stake was Kenvue: 459,706 shares worth $12.1M. The largest sale was Verisk Analytics, an estimated $6.04M.
By sector, the portfolio is most concentrated in Technology at 30% of assets, up from 29% a quarter earlier, followed by Industrials and Healthcare.
- Norris Perne & French's largest Q2 2023 buy was Kenvue: 459,706 shares worth $12.1M.
- Norris Perne & French added most to iShares Russell 1000 Value ETF in Q2 2023, an estimated $3.45M increase.
- Norris Perne & French's biggest Q2 2023 reduction was Verisk Analytics, cutting an estimated $6.04M.
- Norris Perne & French fully exited Bristol-Myers Squibb in Q2 2023, selling an estimated $249K.
- Norris Perne & French's ten largest holdings make up 33% of its $1.19B portfolio in Q2 2023.
- Norris Perne & French opened 5 new positions and closed 8 in Q2 2023.
- Norris Perne & French's portfolio value rose 8.8% quarter-over-quarter to $1.19B.
Based on Norris Perne & French's 13F filing for Q2 2023, filed 19 Jul 2023.